Prophylaxy of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery

• Status: Unknown status
• Trial end date: 2018-01-31
• Target enrollment: 0
• Participant gender: All

Summary

Postoperative nausea and vomiting (PONV) is one of the most commonly reported adverse effects of anesthesia. The general incidence of vomiting is approximately 30%, nausea at 50% and the PONV rate can go up to 80% in high-risk patients without prophylaxis. Prevention of these episodes in high-risk patients improves satisfaction and well-being rates. Therefore, it becomes important the adequate control of PONV, aiming at the satisfaction of the patient with the procedure, lower costs for the health system as well as reduction of complications in the postoperative period. This study aims to evaluate the association of gabapentin or pregabalin with dexamethasone in reducing the incidence of PONV in high-risk patients undergoing laparoscopic surgeries in the first 48 hours postoperatively as well as to assess side effects.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Faculdade de Ciências Médicas da Santa Casa de São Paulo
• Treatments: Gabapentin; gamma-Aminobutyric Acid; Pregabalin

Criteria

Inclusion Criteria:

• Patients undergoing laparoscopic procedures

• Apfel Score 0, I, II, III and IV

• ASA I / II

Exclusion Criteria:

• Patients with surgery converted to open before thirty minutes of surgery

• Patients who were exposed previously to gabapentin or pregabalin Patients who have allergy to any medicine used in the study

• Patient who have to any cognitive impairment

• Illiterate patients

• Patients who refuse to participate in the study